Generic Drug News and Research

RSS
Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.
July issue of Health Affairs examining PEPFAR impact to be discussed at briefing on Tuesday

July issue of Health Affairs examining PEPFAR impact to be discussed at briefing on Tuesday

Clinical results for Teva's biologic oncology candidates presented at MASCC/ISOO 2012

Clinical results for Teva's biologic oncology candidates presented at MASCC/ISOO 2012

U.S. District Court rules in favor of Teva in COPAXONE patent infringement case

U.S. District Court rules in favor of Teva in COPAXONE patent infringement case

No legal recourse because generic drug caused injury

No legal recourse because generic drug caused injury

Teva launches Olanzapine and Fluoxetine Capsules for treatment of depression

Teva launches Olanzapine and Fluoxetine Capsules for treatment of depression

Mylan's new online resource seeks to dispel common misconceptions about generic drugs

Mylan's new online resource seeks to dispel common misconceptions about generic drugs

Senate Appropriations boosts HHS funding on party-line vote as GOP attacks health reform provisions

Senate Appropriations boosts HHS funding on party-line vote as GOP attacks health reform provisions

Positive top-line results from Teva’s GALA Phase III trial on RRMS

Positive top-line results from Teva’s GALA Phase III trial on RRMS

Global generic pharmaceuticals market to reach $231.00 billion in 2017 at 9.29% CAGR

Global generic pharmaceuticals market to reach $231.00 billion in 2017 at 9.29% CAGR

Sihuan's Roxatidine passes Chinese SFDA on-site inspection

Sihuan's Roxatidine passes Chinese SFDA on-site inspection

Is access problem preventing generic drug makers' progress?

Is access problem preventing generic drug makers' progress?

First Edition: May 23, 2012

First Edition: May 23, 2012

Prodigy Generics launches injectable irinotecan

Prodigy Generics launches injectable irinotecan

HCCI's report shows facility prices outpaced general inflation for the privately insured under 65

HCCI's report shows facility prices outpaced general inflation for the privately insured under 65

Teva first quarter net revenues increase 25% to $5.1 billion

Teva first quarter net revenues increase 25% to $5.1 billion

PharMerica first quarter net income increases to $5.6 million

PharMerica first quarter net income increases to $5.6 million

Teva, Mylan settle patent infringement litigation for Nuvigil

Teva, Mylan settle patent infringement litigation for Nuvigil

Leahy introduces generic drug label legislation

Leahy introduces generic drug label legislation

First Edition: April 18, 2012

First Edition: April 18, 2012

Supreme Court rules generic drug makers can challenge branded drug companies' wording in patent applications

Supreme Court rules generic drug makers can challenge branded drug companies' wording in patent applications